Neuralink secures FDA approval for First-in-Human clinical study, opening new frontiers in Neurotechnology.
Neuralink, Elon Musk’s pioneering brain-implant company, has achieved a remarkable milestone by gaining approval from the U.S. Food and Drug Administration (FDA) for its first-in-human clinical study. This breakthrough marks a significant advancement in the field of neurotechnology and brings…